Barclays PLC Grows Stake in Paysign, Inc. (NASDAQ:PAYS)

Barclays PLC increased its holdings in Paysign, Inc. (NASDAQ:PAYS) by 327.4% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 47,090 shares of the company’s stock after buying an additional 36,071 shares during the period. Barclays PLC owned 0.09% of Paysign worth $173,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets grew its stake in Paysign by 257.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 44,793 shares of the company’s stock worth $164,000 after buying an additional 32,245 shares in the last quarter. Bard Associates Inc. bought a new stake in shares of Paysign during the 3rd quarter worth $103,000. Royce & Associates LP purchased a new position in Paysign in the third quarter worth $814,000. GSA Capital Partners LLP increased its stake in Paysign by 31.2% in the third quarter. GSA Capital Partners LLP now owns 117,028 shares of the company’s stock valued at $429,000 after acquiring an additional 27,829 shares during the last quarter. Finally, Joule Financial LLC purchased a new stake in Paysign during the third quarter valued at about $1,478,000. Institutional investors own 25.89% of the company’s stock.

Paysign Price Performance

PAYS stock opened at $2.90 on Wednesday. Paysign, Inc. has a 1 year low of $2.40 and a 1 year high of $5.59. The firm has a 50-day moving average of $3.35 and a 200 day moving average of $3.99. The company has a market cap of $155.29 million, a P/E ratio of 19.33 and a beta of 0.95.

Paysign (NASDAQ:PAYS) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.02. The company had revenue of $15.26 million for the quarter, compared to analyst estimates of $14.96 million. Paysign had a return on equity of 30.64% and a net margin of 14.28%. During the same period in the previous year, the company posted $0.02 earnings per share. On average, equities research analysts expect that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently commented on PAYS shares. Barrington Research reiterated an “outperform” rating and set a $7.00 price objective on shares of Paysign in a research report on Monday, November 4th. Lake Street Capital started coverage on shares of Paysign in a research report on Friday, December 20th. They set a “buy” rating and a $6.00 price target on the stock.

Insider Activity at Paysign

In other Paysign news, CEO Mark Newcomer sold 22,000 shares of the firm’s stock in a transaction that occurred on Monday, October 21st. The shares were sold at an average price of $3.75, for a total transaction of $82,500.00. Following the completion of the transaction, the chief executive officer now owns 9,414,886 shares of the company’s stock, valued at approximately $35,305,822.50. This trade represents a 0.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Topline Capital Partners, Lp sold 20,834 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $3.03, for a total value of $63,127.02. Following the completion of the sale, the insider now directly owns 5,611,128 shares in the company, valued at approximately $17,001,717.84. This represents a 0.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 668,465 shares of company stock valued at $2,187,249 in the last three months. Company insiders own 23.40% of the company’s stock.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.